SAN DIEGO–(BUSINESS WIRE)–Sotera Wireless, maker of the ViSi Mobile® Surveillance Monitoring System and a pioneer in continuous vital signs monitoring, announced today the appointment of veteran engineering and operations executive Younes Achkire, PhD, as its new Chief Operating Officer. With a doctorate from the Free University of Brussels and post-doctorate […]
Financial
ClearFlow Names Michael Elniski VP of Global Sales
ANAHEIM, Calif,–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, has named Michael Elniski its new Vice President of Global Sales. Elniski, who most recently served as Franchise VP of Cardiac Critical Care at Merit Medical and was previously VP of Healthcare Solutions at Edwards Lifesciences, is recognized […]
Itamar Medical Reports First Quarter 2019 Financial Results
– WatchPAT™ Revenues Increase 15% to $5.8 Million – – U.S. WatchPAT Revenues Increase 34% to $4.3 Million – – Total Revenues Increase 11% to $6.1 Million – CAESAREA, Israel, May 21, 2019 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq & TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic […]
Corvidia Therapeutics Announces Dr. Preston Klassen Joins its Board of Directors
WALTHAM, Mass., May 21, 2019 /PRNewswire/ — Corvidia Therapeutics Inc., a clinical stage biotechnology company, today announced the appointment of Dr. Preston Klassen, M.D., M.H.S. to its Board of Directors. Dr. Klassen is presently Executive Vice President, Head of Research and Development at Arena Pharmaceuticals, Inc. (Nasdaq: ARNA). A nephrologist with more than 20 years […]
Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors
Santa Monica, CA, May 20, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that Dr. Jerome B. Zeldis agreed to re-join the Company as an Independent Director, […]
BioCardia Reports 2019 First Quarter Financial Results and Business Highlights
SAN CARLOS, Calif., May 20, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and business highlights for the first quarter of 2019 and filed its quarterly report on Form 10-Q for the three months ended March […]
Neovasc Announces Closing of Private Placement of Convertible Debt and Common Shares for Gross Proceeds of US$11.5 Million
VANCOUVER, May 16, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ:NVCN)(TSX:NVCN) announced today that it has closed its previously announced private placement (the “Private Placement”) of (i) a 15% original issue discount convertible debenture (the “Debenture”) with a face value of US$11.5 million, for gross proceeds to the Company of US$9,775,000, and […]
Medical Device Industry Veteran Rob Abrams to Join Evolve Team
SOLANA BEACH, Calif.–(BUSINESS WIRE)–Evolve Medtech Partners, a medical device development company and incubator, is pleased to announce that Rob Abrams has joined the company as a partner. “We’ve had the pleasure of getting to know Rob over a number of years and recognize him as an exceptionally talented executive with an impressive […]
Shockwave Appoints Keith D. Dawkins M.D. as Chief Medical Officer
SANTA CLARA, Calif., May 15, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the Company has appointed Keith D. Dawkins, M.D. as Chief Medical Officer. “Given the challenges associated […]
InspireMD Announces First Quarter 2019 Financial Results
TEL AVIV, Israel, May 14, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced results for the first quarter ending March 31, 2019. First Quarter 2019 and […]



